Relay Therapeutics, Inc.
RLAY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $899,872 | $592,576 | $443,391 | $689,431 |
| - Cash | $91,564 | $113,941 | $93,542 | $124,287 |
| + Debt | $33,329 | $34,183 | $47,159 | $48,502 |
| Enterprise Value | $841,637 | $512,818 | $397,008 | $613,646 |
| Revenue | – | $677 | $7,679 | $0 |
| % Growth | – | -91.2% | – | – |
| Gross Profit | -$748 | $677 | $7,679 | $0 |
| % Margin | – | 100% | 100% | – |
| EBITDA | -$73,401 | -$75,845 | -$83,661 | -$83,645 |
| % Margin | – | -11,203.1% | -1,089.5% | – |
| Net Income | -$74,149 | -$70,375 | -$77,065 | -$76,004 |
| % Margin | – | -10,395.1% | -1,003.6% | – |
| EPS Diluted | -0.43 | -0.41 | -0.46 | -0.45 |
| % Growth | -4.9% | 10.9% | -2.2% | – |
| Operating Cash Flow | -$62,119 | -$55,261 | -$73,210 | -$57,868 |
| Capital Expenditures | $1 | -$26 | -$384 | $0 |
| Free Cash Flow | -$62,118 | -$55,287 | -$73,594 | -$57,868 |